Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2.
about
Characterization and Functions of Protease-Activated Receptor 2 in Obesity, Diabetes, and Metabolic Syndrome: A Systematic ReviewAntidiabetic treatment with gliptins: focus on cardiovascular effects and outcomesDPP4 in DiabetesComparative safety for cardiovascular outcomes of DPP-4 inhibitors versus glimepiride in patients with type 2 diabetes: A retrospective cohort studyDipeptidyl peptidase-4 expression in pancreatic tissue from patients with congenital hyperinsulinismMicroflora Disturbance during Progression of Glucose Intolerance and Effect of Sitagliptin: An Animal StudyDipeptidyl Peptidase 4 Distribution in the Human Respiratory Tract: Implications for the Middle East Respiratory Syndrome.Dipeptidyl peptidase-4 is highly expressed in bronchial epithelial cells of untreated asthma and it increases cell proliferation along with fibronectin production in airway constitutive cells.Inflammation, glucose, and vascular cell damage: the role of the pentose phosphate pathway.Ameliorating Effect of Gemigliptin on Renal Injury in Murine Adriamycin-Induced Nephropathy.Strong Association between Plasma Dipeptidyl Peptidase-4 Activity and Impaired Cognitive Function in Elderly Population with Normal Glucose Tolerance.Dipeptidyl peptidase-4 inhibition: insights from the bench and recent clinical studiesCD26 and Asthma: a Comprehensive Review.Glucagon-like peptide 1: A potential anti-inflammatory pathway in obesity-related asthma.Protease-Activated Receptor 2 Promotes Pro-Atherogenic Effects through Transactivation of the VEGF Receptor 2 in Human Vascular Smooth Muscle Cells.Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease.LAPS Insulin115: A novel ultra-long-acting basal insulin with a unique action profile.Dipeptidyl Peptidase-4 Inhibitor Anagliptin Prevents Intracranial Aneurysm Growth by Suppressing Macrophage Infiltration and Activation.KDM3A inhibition attenuates high concentration insulin‑induced vascular smooth muscle cell injury by suppressing MAPK/NF‑κB pathways.Protease activated-receptor 2 is necessary for neutrophil chemorepulsion induced by trypsin, tryptase, or dipeptidyl peptidase IV.Dipeptidyl peptidase 4 inhibitors attenuates the decline of skeletal muscle mass in patients with type 2 diabetes.Cyclic Nucleotide-Directed Protein Kinases in Cardiovascular Inflammation and Growth.Plasma Dipeptidyl Peptidase-4 Activity, a Novel Biomarker or Even a Possible Therapeutic Target for Depression in Type 2 Diabetic Patients: Results from a Cross-Sectional Study in China.Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes.Effects of linagliptin on human immortalized podocytes: a cellular system to study dipeptidyl-peptidase 4 inhibition.Adipokines enhance oleic acid-induced proliferation of vascular smooth muscle cells by inducing CD36 expression.Linagliptin inhibits lipopolysaccharide-induced inflammation in human U937 monocytesThe dipeptidyl peptidase-4 (DPP-4) inhibitor teneligliptin enhances brown adipose tissue function, thereby preventing obesity in mice
P2860
Q26752383-B9126BD8-69F3-480B-AEE6-CE51F555813BQ26785454-B81DF7F1-7B00-481A-80C2-3DCD0BAFB1DFQ26797335-91002AC3-1B94-44D0-BC37-1B5E8B347F9FQ33833732-71570AA5-9CCF-4614-BAE3-6CA5785DFBDFQ36014334-ADEDC4E9-17B1-4C5A-9DB7-FD77244BCF46Q36133669-ECE6EECC-F04C-40C5-8371-D771B1E7847EQ36468760-634C1E2A-F2E6-4916-99C2-9A0A2983218FQ36687153-BE61B755-F730-41C3-A826-60E384315770Q36955142-31F5E7C6-D5AC-45C5-9E07-7861AEAB0893Q38404674-9F391D97-DC56-49BA-801E-1CF200BAC9F9Q38629516-41A621BB-72DA-47F5-BD4D-2FC1D61C0460Q38912469-51138711-B274-4026-AD00-3055B1DBC5C8Q38937243-DC87128D-DE64-4F1A-A8F8-9011300DFFD9Q39397467-3E6D1523-68BC-44B6-A094-111A131ECF3AQ40630385-EA03FD69-8FE4-42C1-9CA1-0E6B178B6546Q42377919-C8F21640-4345-4F9E-97DB-8B4883B749C2Q42509647-F758AD09-BE19-4B1C-960C-A468BBF8A240Q43163467-DD7FBC81-EC7B-4891-A5AD-2AD54D8566B8Q47246628-C92003A0-2EFB-407B-A96B-590EE0A1084DQ47551897-9A4872C7-93AC-483C-BDB8-DA4DACB7588CQ47603611-69B2B4B6-3210-4B3A-9A12-98B1E643A305Q47713533-73BBA518-707A-4C64-9037-31F0A2FA252FQ47845951-910FBB84-4185-4F18-9A10-45FCDEC5F49AQ47988627-8F228E75-21A4-4AF4-99E4-D51605B267A7Q51146865-7167F068-1BD6-4789-A337-A5BFC129ECBCQ53443614-3043C61A-6607-48E6-B25B-BAD7050DFBECQ57111484-689F691A-F1A9-4767-899B-D89F992BCB52Q58553672-F09AFEB5-C80E-4C03-B8E0-A6A33B47B3F1
P2860
Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Soluble DPP4 induces inflammat ...... protease-activated receptor 2.
@en
Soluble DPP4 induces inflammat ...... protease-activated receptor 2.
@nl
type
label
Soluble DPP4 induces inflammat ...... protease-activated receptor 2.
@en
Soluble DPP4 induces inflammat ...... protease-activated receptor 2.
@nl
prefLabel
Soluble DPP4 induces inflammat ...... protease-activated receptor 2.
@en
Soluble DPP4 induces inflammat ...... protease-activated receptor 2.
@nl
P2093
P50
P1476
Soluble DPP4 induces inflammat ...... protease-activated receptor 2
@en
P2093
Carlos F Sánchez-Ferrer
Jürgen Eckel
Laura A Villalobos
Nina Wronkowitz
Sven W Görgens
P304
P356
10.1016/J.BBADIS.2014.06.004
P577
2014-06-11T00:00:00Z